Answers are grounded in this paper and cite their sources.
This study aimed to evaluate tryptophan and its metabolite kynurenine as possible diagnostic biomarkers for Juvenile Idiopathic Arthritis (JIA) and their role in therapeutic decision-making.The levels of tryptophan (Trp) and kynurenine (Kyn) in 44 sera and nine samples of synovial fluid (SF) of 25 children with JIA were compared with 18 sera of peers with non-inflammatory diseases. Trp and Kyn concentrations were determined by reverse-phase high-performance liquid chromatography (RP-HPLC). Serum levels in JIA patients did not significantly differ from those of the control group. The comparison of SF with serum levels revealed that Trp in SF (mean 57.2 SD 19.5 mol/L) was lower than in serum (mean 36.3 SD 18.4 mol/L). Therefore, the Kyn/Trp ratio was higher (mean 77.8 SD 44,4 vs. 41.6 13.7 mol/ mmol). There exists a significant positive association between neopterin concentrations and tryptophan breakdown as expressed by the kyn/trp ratio (rs = 0,427, p<0.01) indicating an involvement of indoleamine 2,3-dioxygenase (IDO-1) in the breakdown of tryptophan. However, this was localized only in the SF. Conclusion: The analyzed parameters did not show relevant differences in serum levels between patients and the control group. However, the SF from JIA patients did show a significantly decreased Trp concentration and a higher Kyn/Trp ratio. This finding suggests a local upregulation of tryptophan breakdown due to increased IDO-activity in inflamed joints.
No takes yet. Share an insight, caveat, or question.
Jürgen Brunner (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: